DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Kallikrein 13
Kallikrein 13
Serine Proteases with Altered Sensitivity to Activity-Modulating
R&D Assay for Alzheimer's Disease
Hereditary Angioedema: How to Approach It at the Emergency Department?
Kallikrein 13: a New Player in Coronaviral Infections
Proteome Profiler Human Protease Array Kit
Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
Prostatic Trypsin-Like Kallikrein-Related Peptidases
Activation Profiles and Regulatory Cascades of the Human Kallikrein-Related Peptidases Hyesook Yoon
Somamer Reagents Generated to Human Proteins Number Somamer Seqid Analyte Name Uniprot ID 1 5227-60
Kallikrein 13 Antibody Pair [HRP] NBP2-79509 Manual
Natural and Engineered Kallikrein Inhibitors: an Emerging Pharmacopoeia
Natural and Synthetic Inhibitors of Kallikrein-Related Peptidases (Klks)
Table 5. Probesets (54) Representing the Top 50 Transcripts Identified by PAM That Delineate Lung Adenocarcinomas with NED from Non-NED Lung Adenocarcinomas
Kallikrein-Related Peptidase Signalling Via Proteinase-Activated Receptors
Human KLK13 / Kallikrein-13 Protein (His Tag)
Sequence and Evolutionary Analysis of the Human Trypsin Subfamily of Serine Peptidases
For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group
Development of Chemical Tools to Monitor Human Kallikrein 13 (KLK13) Activity
Top View
All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer
Signal Transduction Discover
Glycerol-3-Phosphate Is a FGF23 Regulator Derived from the Injured Kidney
Complex Formation Between Human Kallikrein 13 and Serum Protease Inhibitors
(12) United States Patent (10) Patent No.: US 9,636,359 B2 Kenyon Et Al
Proteolytic Processing of Human Growth Hormone by Multiple Tissue Kallikreins and Regulation by the Serine Protease Inhibitor Kazal-Type5 (SPINK5) Protein
Position Amino Acid MSA Conservation (%) TMPRSS2
Human Kallikrein 13 Expression in Normal Tissues: an Immunohistochemical Study
The Hepatic Clearance of Recombinant Tissue-Type Plasminogen Activator Decreases After an Inflammatory Stimulus
Kallikrein-Related Serine Peptidases and Nodal in Prostate Cancer
Multiple Tissue Kallikrein Mrna and Protein Expression in Normal Skin and Skin Diseases N
The Tumor Proteolytic Landscape: a Challenging Frontier in Cancer Diagnosis and Therapy
Human Protease/Protease Inhibitor Array Kit
Human Kallikrein 3/PSA Quantikine
Primary Tumor Levels of Human Tissue Kallikreins Affect Surgical
Natural and Engineered Kallikrein Inhibitors: an Emerging Pharmacopoeia
Table S2. Protein Identities Included in PEA Immunoassay No. Protein
Human Kallikrein 13 Antibody Antigen Affinity-Purified Polyclonal Goat Igg Catalog Number: AF2625
Tissue-Specific Promoter Utilisation of the Kallikrein-Related Peptidase
Andrew Ramsay Thesis (PDF 2MB)
WO 2014/152940 Al 25 September 2014 (25.09.2014) P O P C T
Elevated Human Tissue Kallikrein Levels in the Stratum Corneum and Serum of Peeling Skin Syndrome-Type B Patients Suggests an Over-Desquamation of Corneocytes
This Article Was Published in an Elsevier Journal. the Attached Copy
Sweetened Kallikrein-Related Peptidases (Klks): Glycan Trees As Potential Regulators of Activation and Activity
The Emerging Roles of Human Tissue Kallikreins in Cancer
Substrate Specificity of Kallikrein-Related Peptidase 13
In Adenoid Cystic Carcinoma